Till Koch

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Till Koch, Christine Dahlke, Anahita Fathi et al. · The Lancet Infectious Diseases · 2020 · 171 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series

Christine Dahlke, Jasmin Heidepriem, Robin Kobbe et al. · medRxiv · 2020 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Leonie M. Weskamm, Anahita Fathi, Matthijs P. Raadsen et al. · Cell Reports Medicine · 2022 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series

Jasmin Heidepriem, Christine Dahlke, Robin Kobbe et al. · Pathogens · 2021 · 27 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins

Till Koch, Monika Rottstegge, Paula Ruibal et al. · Viruses · 2020 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17